Navigation Links
Original research papers on acute cardiovascular care: ESC launches EHJ-ACVC
Date:4/25/2012

Sophia Antipolis, France, 19 April 2012: The European Society of Cardiology (ESC) announced today the launch of the European Heart Journal: Acute Cardiovascular Care, the organisation's official journal of the ESC Working Group on Acute Cardiac Care.

"This new journal will be an important resource and guidance for cardiologists and allied healthcare professionals, offering useful information for daily clinical practice to improve the diagnosis, treatment and outcome of patients with acute cardiovascular syndromes," said Editor in Chief Professor Christiaan Vrints. Professor Vrints, Chairman of the Department of Cardiology at Antwerp University Hospital in Belgium, is also Chairperson of the ESC's Working Group on Acute Cardiac Care.

The journal will also have a strong educational focus that covers the full range of science in acute cardiovascular diseases, including original research papers, editorials, educational materials, clinical case studies, practical tips and how-to articles.

This first issue of the journal, which is published by SAGE, has contributions by highly regarded cardiologists including Harvard Medical School Professor Eugene Braunwald, Professor Thomas Lscher , Chairman of Cardiology at the University Hospital Zurich and Director of CardioVascular Research at the Institute of Physiology of the University of Zurich; and Professor Eric Boersma from the Erasmus University Medical Center in Rotterdam, Netherlands.

Highlights from the first issue include:

The treatment of Acute Myocardial Infarction (AMI): the Past, the Present, and the Future

This review showed that early reperfusion therapy is critically important in preventing ischemic necrosis in patients with AMI, although reperfusion can also injure the muscles and tissue around the heart. Yet there is continual and promising research that may show how to reduce myocardial reperfusion injury when treating patients with AMI.

Primary PCI (pPCI) during off-hours is not related to increased mortality

There is continuous research to determine whether or not the quality of care delivered to heart attack patients differs during the day or at night due to variations in symptom onset to treatment time, physician performance, coronary care staff and appropriate hospital equipment. In this particular study, most patients who underwent pPCI in a high-volume medical center during off hours showed similar short and long-term results compared to those undergoing the procedure during regular hours.

ST-Segment Elevation Myocardial Infarction (STEMI) mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network program

Previous randomised trials have demonstrated that transferring patients to percutaneous coronary intervention (PCI)-capable hospitals for pPCI treatment leads to better outcomes than administering thrombolytic therapy at community hospitals. Subsequent research examining local STEMI networks focused mainly on PCI-related time issues and outcomes of pPCI patients whereas data on patients that were not transferred are lacking. In this study, a STEMI network with greater than 70% use of pPCI showed similar mortality rates between community hospitals (71% use of pPCI and 20% of thrombolysis therapy) and PCI-capable hospitals (93% use of pPCI). Participation in the STEMI network program was associated with an increased adherence to reperfusion guidelines over time. This study strongly supports the promotion and implementation of STEMI networks in all areas with a limited availability of PCI-capable hospitals.

New oral anticoagulant agents after Acute Coronary Syndromes (ACS)

The benefit of adding vitamin K antagonists (VKA) with antiplatelet therapy in order to prevent ischemic events after an ACS like chest pain, has been successfully studied, yet the long-term use of VKA is not recommended due to their need for frequent monitoring and drug and dietary interactions. The new oral anticoagulants offer several advantages compared to VKA, like absence of frequent monitoring. This review evaluates the current evidence and practical consequences between the use of oral anticoagulant agents and oral anti factor Xa inhibitors.


'/>"/>

Contact: ESC Press Office
press@escardio.org
33-492-947-756
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. National Study Reports Staggering Spending Increases Among Seniors With Chronic Conditions Through Original Medicare - Special Needs Plan Program Offers Solution For Those In Texas
2. Tahitian Noni Juice Is Now Tahitian Noni Original Bioactive Beverage
3. Australia Souvenir Gift Shop Donates 10% Of Profits To Help Aboriginal Children
4. Breast Cancers Return in Original Tumor Site a Bad Sign
5. End Thunderstorm and Fireworks Fear with The Original Anxiety Wrap
6. Hidden Pond Productions Announces a Unique One-Stop Shop of Music/Talent Supervisions, IP Licensing and Original Custom Music
7. Hemostatic drug less effective than originally predicted
8. AIUM unveils original features at 2011 convention
9. Second Heart Attack Not Always Tied to Original Blockage
10. Recurring cancers in women with a history of breast cancer differ from the original tumors
11. Window of opportunity to treat some stroke patients may be longer than originally suspected
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... , ... Providing for loved ones before one’s passing is of paramount importance. ... begin. “Now more than ever there are some questions that are far too critical ... said attorney Lisa Edgar Dickman, founder of the Law Offices of Lisa Edgar Dickman. ...
(Date:4/21/2017)... CA (PRWEB) , ... April 21, 2017 , ... ... to experienced, personalized dental care since 1985. After thirty-two years, Dr. Latner has become ... privilege to help my numerous clients over the years with all their dental needs,” ...
(Date:4/21/2017)... Miami, Fl (PRWEB) , ... April 21, 2017 , ... ... Earth Day is a day to clean, plant trees and look forward to a ... green isn’t just about doing something outdoors. Indoor air quality can be two to ...
(Date:4/21/2017)... ... April 21, 2017 , ... Federal ... five common elements between the Obamacare program that most Republicans love to hate ... Warfarin poison to kill hogs. , Like Obamacare, the Miller program centers ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... a significant bandwidth upgrade infrastructure service to Tele-Media Solutions. IFN is delivering ... of IFN’s consortium member-owners, Tele-Media Solution’s protect transport with 3GB Dual Access Internet ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  IRIDEX Corporation (Nasdaq: IRIX ... for the first quarter 2017 after the close of ... team will host a corresponding conference call beginning at ... Investors interested in listening to the conference call may ... or (703) 326-3030 for international callers, using conference ID: ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, ... antibody-centric, clinical-stage biopharmaceutical company developing new treatments for ... the closing of its previously announced underwritten public ... at a public offering price of $2.00 per ... estimated offering expenses payable by Sorrento.  The net ...
(Date:4/18/2017)... 18, 2017  Cardinal Health (NYSE: CAH ... 2017 earnings per share (EPS) guidance and providing a ... in conjunction with this morning,s announcement of the planned ... Nutritional Insufficiency businesses. Cardinal Health now believes ... be at the bottom of its previous guidance range ...
Breaking Medicine Technology: